Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Faries

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|August 30, 2017
<i>Mycobacterium bovis</i> Bacillus Calmette-Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage FunctionRicardo D Lardone, Alfred A Chan, Agnes F Lee, et al.
Frontiers in Immunology|January 1, 2025
NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesisKuldeep Makwana, Edwin J Velazquez, Diego M Marzese, et al.
Surgery|February 2, 2010
Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trialNabil Wasif, Mark B Faries, Sukamal Saha, et al.
JAMA Surgery|April 7, 2017
Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic TherapyGary B Deutsch, Devin C Flaherty, Daniel D Kirchoff, et al.
Clinical & Experimental Metastasis|October 15, 2021
The lymphatic system and sentinel lymph nodes: conduit for cancer metastasisStanley P Leong, Alexander Pissas, Muriel Scarato, et al.
Annals of Surgical Oncology|November 4, 2016
Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to PrognosisGiorgos Karakousis, Phyllis A Gimotty, Edmund K Bartlett, et al.
Journal of Surgical Oncology|August 23, 2011
Local and intralesional therapy of in-transit melanoma metastasesAlessandro Testori, Mark B Faries, John F Thompson, et al.
Cancer Investigation|July 31, 2007
A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patientsMark B Faries, Rishab K Gupta, Xing Ye, et al.
Annals of Surgical Oncology|November 21, 2015
Predictors and Survival Impact of False-Negative Sentinel Nodes in MelanomaDavid Y Lee, Kelly T Huynh, Annabelle Teng, et al.
The American Surgeon|October 15, 2015
Adrenalectomy for Metastatic Melanoma: Current Role in the Age of Nonsurgical TreatmentsDevin C Flaherty, Gary B Deutsch, Daniel D Kirchoff, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|August 30, 2017
<i>Mycobacterium bovis</i> Bacillus Calmette-Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage FunctionRicardo D Lardone, Alfred A Chan, Agnes F Lee, et al.
Frontiers in Immunology|January 1, 2025
NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesisKuldeep Makwana, Edwin J Velazquez, Diego M Marzese, et al.
Surgery|February 2, 2010
Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trialNabil Wasif, Mark B Faries, Sukamal Saha, et al.
JAMA Surgery|April 7, 2017
Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic TherapyGary B Deutsch, Devin C Flaherty, Daniel D Kirchoff, et al.
Clinical & Experimental Metastasis|October 15, 2021
The lymphatic system and sentinel lymph nodes: conduit for cancer metastasisStanley P Leong, Alexander Pissas, Muriel Scarato, et al.
Annals of Surgical Oncology|November 4, 2016
Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to PrognosisGiorgos Karakousis, Phyllis A Gimotty, Edmund K Bartlett, et al.
Journal of Surgical Oncology|August 23, 2011
Local and intralesional therapy of in-transit melanoma metastasesAlessandro Testori, Mark B Faries, John F Thompson, et al.
Cancer Investigation|July 31, 2007
A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patientsMark B Faries, Rishab K Gupta, Xing Ye, et al.
Annals of Surgical Oncology|November 21, 2015
Predictors and Survival Impact of False-Negative Sentinel Nodes in MelanomaDavid Y Lee, Kelly T Huynh, Annabelle Teng, et al.
The American Surgeon|October 15, 2015
Adrenalectomy for Metastatic Melanoma: Current Role in the Age of Nonsurgical TreatmentsDevin C Flaherty, Gary B Deutsch, Daniel D Kirchoff, et al.
Pageof 15